Records containing: Stage IV Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-04-21Phase I Study To Evaluate The Use Of Autologous T- Antigen-Presenting Cells (T-APC) To Enhance The Persistence Of Adoptively Transferred CD8+ Antigen-Specific T Cells (CTL) Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-04-10Phase 1 Study of the Combination of BAY 43-9006 (Sorafenib) and CCI-779 (Temsirolimus) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-01-27A Phase 2 Study of AZD0530 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-01-20A Phase 2 Study of Dasatinib in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-10-28Phase II Trial of Carboplatin, Weekly Paclitaxel and Biweekly Bevacizumab in Patients With Unresectable Stage IV Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-10-16A Phase II Trial of Intravenous Administration of Reovirus Serotype 3 - Dearing Strain (Reolysin®) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-06A Phase II Study Using a Peptide Vaccine With or Without Aldesleukin Following a Lymphodepleting Chemotherapy and Reinfusion of Autologous Lymphocytes Depleted of T Regulatory Lymphocytes in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-05Phase II Trial of Interleukin-12 (NSC #672423, IND #6798) Followed by Interferon Alfa-2B in Patients With Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-05PHASE II TRIAL OF R115777 IN PATIENTS WITH METASTATIC MALIGNANT MELANOMA
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase 2 Study of EMD 121974 (Cilengitide, NSC 707544) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-23Phase II Trial of mTOR Inhibitor Temsirolimus Combined With MEK Inhibitor AZD 6244 in Patients With BRAF Mutant Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-03A Phase 1 Study of 5-azacitidine in Combination With Interferon-Alfa 2B in Unresectable or Metastatic Melanoma and Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2013-05-03A Phase I Study of Intravenous CCI-779 in Combination With Bryostatin-1 in Solid Tumors (10038414)
-
CLINICAL_TRIALS study record update · 2013-04-10Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.
-
CLINICAL_TRIALS study record update · 2013-04-10Phase II Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) Diluted in EPL Diluent (NSC #704057) in Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2013-03-08A Phase 1 Study of AZD2171 and WBRT in Patients With Brain Metastases
-
CLINICAL_TRIALS study record update · 2013-03-05A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for the Treatment of Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Study Of The Toxicities, Biologic And Clinical Effects Of Daily 5 Aza 2'Deoxycytidine (DAC), NSC 127716 (IND 50733) For Four Weeks In Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-31A Pilot Trial to Evaluate the Molecular Effects of RO4929097 as Neoadjuvant Therapy for Resectable Stage IIIB, IIIC or IV Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase II Study Of Epothilone B Analog BMS 247550 (NSC # 710428) In Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-25Melanoma Vaccines: Differentiation Antigen Peptides (MART-1:27-35, Tyrosinase and Gp-100) as Immune Targets
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase II Trial of SU5416 (NSC #696819) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II Study Of Temozolomide And Thalidomide In Patients With Metastatic Melanoma In The Brain
-
CLINICAL_TRIALS study record update · 2013-01-16Phase II Study of Melanoma Vaccine (NSC #683472/675756, IND #6123) and Low-Dose, Subcutaneous Interleukin-2 in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase II Study of PS-341 in the Treatment of Metastatic Malignant Melanoma